Cancer Care Value-Learning From Others
Getting Smarter in How We Score and Promote Value
Value-Based Reimbursement in Oncology
Getting On Pathway?
Testing for ALK-Positive NSCLC
Signaling the Future of Personalized Medicine
Prostate Cancer
Long-Term Breast Cancer Patient Follow-Up Care
Money Well Spent?
Myeloproliferative Disorders and Myelofibrosis
BRCA1/2 Genetic Testing Found Cost-Effective in Current Era
SABCS Conference Coverage
Trends in the 2012 Eisai Oncology Digest: Patient Demographics and Cancer Treatment Goals
This article was sponsored by Eisai Inc. The 2012 Eisai Oncology Digest was commissioned and funded by Eisai Inc.
Literature Review
Multiple Myeloma: Pre-Transplant Induction, Consolidation, and Maintenance Therapy
On the Horizon for Multiple Myeloma
Availability of Newer Agents May Lower Healthcare Costs
Oncology Hit Hard by SGR Debacle
Interview With Allen S. Lichter, MD, Chief Executive Officer, American Society of Clinical Oncology
Forging a Pathway to Quality Cancer Care
UPMC Oncologists: Pioneers in the Clinical Pathways Movement
Is Provenge Angst a Symbol or Symptom of the Times?
Chronic Myelogenous Leukemia
